• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[内耳疾病的流变学治疗效果]

[Rheological therapeutic effects in diseases of the inner ear].

作者信息

Hörmann K, Bernal Sprekelsen M

机构信息

Departamento de O.R.L. Hospital General de Kaiserlautern/R.F.A.

出版信息

An Otorrinolaringol Ibero Am. 1990;17(4):397-404.

PMID:1699442
Abstract

The aim of the rheological treatment in sudden deafness is the improvement of the microcirculation in the inner ear by hemodilution and decreased viscosity of the blood. Both parameters have been checked in two groups of patients suffering from sudden deafness; one treated with Dextran-40 and Pentoxifylline, the other with Dextran-40 only. Improvement of rheological characteristics of blood was statistically significant in the combined therapy with Dextran-40 and Pentoxifylline. Two cohorts of sudden deafness patients--one selected, one non selected--treated with Pentoxifylline and Dextran 40 have been evaluated in respect of hearing improvement under this rheological results compared with the spontaneous remission rate given by Weinaug in 1984.

摘要

突发性耳聋的流变学治疗目的是通过血液稀释和降低血液粘度来改善内耳的微循环。这两个参数已在两组突发性耳聋患者中进行了检查;一组用低分子右旋糖酐-40和己酮可可碱治疗,另一组仅用低分子右旋糖酐-40治疗。低分子右旋糖酐-40和己酮可可碱联合治疗时,血液流变学特性的改善具有统计学意义。根据这一流变学结果,对两组突发性耳聋患者(一组为选定患者,一组为非选定患者)用己酮可可碱和低分子右旋糖酐40治疗后的听力改善情况进行了评估,并与韦瑙格1984年给出的自然缓解率进行了比较。

相似文献

1
[Rheological therapeutic effects in diseases of the inner ear].[内耳疾病的流变学治疗效果]
An Otorrinolaringol Ibero Am. 1990;17(4):397-404.
2
Rheological effects of pharmacological treatment of inner ear disorders.内耳疾病药物治疗的流变学效应
Scand Audiol Suppl. 1986;26:47-8.
3
[Experiences in therapy of acute labyrinthine deafness with low-molecular dextran, pentoxifyllin and nicotinic acid (author's transl)].
Laryngol Rhinol Otol (Stuttg). 1981 Jul;60(7):361-3.
4
[Course and prognosis in sudden deafness].
HNO. 1984 Aug;32(8):341-5.
5
On haemodilution therapy for patients with sudden loss of hearing: clinical and rheological results.突发性听力丧失患者的血液稀释疗法:临床及流变学结果
Klin Wochenschr. 1986 Oct 15;64(20):1058-61.
6
[Randomized double-blind study of therapy of sudden deafness: initial results].
HNO. 1988 Oct;36(10):417-22.
7
[Fibrinolytic therapy in sudden deafness with recombinant tissue-type plasminogen activator. Hemorheologic and therapeutic effects].
Laryngorhinootologie. 1991 Jul;70(7):353-8. doi: 10.1055/s-2007-998052.
8
Effects of pentoxifylline and nitroprusside on guinea pig cochlear blood flow in relationship to various hematocrit values.己酮可可碱和硝普钠对豚鼠耳蜗血流的影响与不同血细胞比容值的关系。
Eur Arch Otorhinolaryngol. 1996;253(6):345-50. doi: 10.1007/BF00178290.
9
[The effect of combined treatment in chronic congestive heart failure with digoxin, furosemide and pentoxifylline upon blood viscosity].地高辛、呋塞米和己酮可可碱联合治疗慢性充血性心力衰竭对血液粘度的影响
Pol Arch Med Wewn. 1990 Nov;84(5):309-20.
10
Treatment of vascular inner ear disease with pentoxifylline: a 4-week, controlled, randomized trial.己酮可可碱治疗血管性内耳疾病:一项为期4周的对照随机试验。
Angiology. 2002 Jan-Feb;53 Suppl 1:S19-22.